Integrated Programs enabled by Translational Pharmaceutics at Quotient Sciences

DIA Europe 2026

Rotterdam, Netherlands | 24 March 2026 - 26 March 2026
Overview

Connect with Quotient Sciences’ experts who will be attending the DIA Europe 2026 event taking place in Rotterdam on March 24-26, 2026 

Meet our Business Development team to learn more about our expanded capabilities and how we can help you with your next project. 

You can schedule a partnering meeting with our experts by using the button below. 

Request a meeting with us:
Location
Rotterdam Ahoy
Ahoyweg 10, 3084 BD
Rotterdam, Netherlands

Meet our experts:

We look forward to meeting you at the DIA Europe 2026 this March.

Ciaran Flanagan

VP, Global Commercial Translational Pharmaceutics

Ciaran Flanagan is the VP, Commercial at Quotient Sciences, leading a business development team specialising in Quotient’s unique ...

About Ciaran
Christian Hoenig

Director, Business Development

Christian Hoenig is a Business Development Director at Quotient Sciences specialising in new business within the Nordic and BeNeLu...

About Christian

More insight from our experts:

Read More
Drug Product, Commercial Manufacturing, Clinical Trial Manufacturing, Translational Pharmaceutics, Regulatory, Orphan Rare, FDA Navigating Expedited Drug Development Pathways Globally: Q&A with Quotient Sciences Experts
Read More
Drug Development Consulting, Translational Pharmaceutics, Formulation Development, Drug Product, Careers The Strategic Role of Drug Development Consultants at Quotient Sciences
Read More